The Food and Drug Administration on Friday approved Eli Lilly’s weight-loss drug Zepbound to treat sleep apnea, a common but ...

When you eat is a very important part of your weight loss journey. Follow these expert-approved suggestions to shed those extra ... While many might think that having a calorie-deficit diet is all ...

The Food and Drug Administration has approved Zepbound, a GLP-1 weight-loss drug from Eli Lilly & Co., for the treatment of moderate to severe sleep apnea certain patients with obesity.

Before Eli Lilly's weight loss drug was approved by the Food and Drug Administration for sleep apnea, getting it off-label was challenging. “Off-label prescribing carries complexities,” Dr ...

The US Food and Drug Administration on Friday approved the first prescription medicine for obstructive sleep apnea: the weight-loss drug Zepbound. The medicine, part of the class known as GLP-1 ...

The U.S. Food and Drug Administration (FDA) recently approved Zepbound® (tirzepatide ... OSA symptoms while also promoting significant weight loss. Zepbound is an injectable prescription ...

“Most Americans eat more sodium than recommended,” says Cara Harbstreet, registered dietitian and owner of Street Smart ...

By Dani Blum The Food and Drug Administration on Friday approved the weight loss drug Zepbound to treat obstructive sleep apnea. It is the first prescription medication approved to treat the ...

Dec. 21 (UPI) --Zepbound, the new GLP-1 weight-loss drug from Eli Lilly & Co., has been approved by the Food and Drug Administration for treating moderate to severe obstructive sleep apnea.